These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11787128)

  • 21. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Gardner JG; Bapat B; Kramer C
    Eval Program Plann; 2008 May; 31(2):136-44. PubMed ID: 18359084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chapter 19: Cost-effectiveness of cervical cancer screening.
    Goldie SJ; Kim JJ; Myers E
    Vaccine; 2006 Aug; 24 Suppl 3():S3/164-70. PubMed ID: 16950004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 24. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
    Wong G; Howard K; Webster A; Chapman JR; Craig JC
    Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening at the general pratitioner].
    Füessl HS
    MMW Fortschr Med; 2010 Oct; 152(40):34. PubMed ID: 21049639
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
    Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
    J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 28. The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening.
    Mandelblatt J; Lawrence W; Yi B; King J
    Arch Intern Med; 2004 Feb; 164(3):245-7; discussion 247-8. PubMed ID: 14769618
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controversial reform plan. Should early cancer diagnosis be required? (interview by Dr. Beate Schumacher)].
    Kleeberg UR
    MMW Fortschr Med; 2006 Nov; 148(44):6-7. PubMed ID: 17619429
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].
    van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1569-71. PubMed ID: 12224477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scan-and-treat methodology using Azure A fast stain as a cost-effective cervical cancer screening alternative to visual inspection with acetic acid.
    Guillaud M; Benedet JL; Follen M; Crain BT; MacAulay C
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S256-9. PubMed ID: 17825881
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
    Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New technologies in cervical cancer screening.
    Gravitt PE; Coutlée F; Iftner T; Sellors JW; Quint WG; Wheeler CM
    Vaccine; 2008 Aug; 26 Suppl 10():K42-52. PubMed ID: 18847556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E; Le Galès C; Cochand-Priollet B; Cartier I; de Crémoux P; Vacher-Lavenu MC; Vielh P; Coste J
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resources for prevention?].
    MMW Fortschr Med; 2006 Dec; 148(51-52):62-3. PubMed ID: 17619351
    [No Abstract]   [Full Text] [Related]  

  • 38. Cervical screening.
    Gray B; Regan G
    N Z Med J; 1994 Aug; 107(984):340. PubMed ID: 8072734
    [No Abstract]   [Full Text] [Related]  

  • 39. Utility of mass screening programmes in health.
    Kayima JK
    East Afr Med J; 1997 Aug; 74(8):465-6. PubMed ID: 9487408
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.